The results suggested that the progression of AS-IV in the suppression of cervical cancer invasion is related to cell signaling transduction, secondary metabolite biosynthesis, and transmembrane transport, and especially might target DCP1A and TMSB4X. Here, DCP1A is linked to cervical carcinoma.